F-Substitution for Achieving Multiferroicity in In (III)-Based Two-Dimensional Organic–Inorganic Hybrid Halogen Double Perovskites
Crystal Growth & Design · 20.08.2025 · 25 (16) · 6803-6809
DOI: 10.1021/acs.cgd.5c00747 ↗Kurz gefasst
Fachartikel in der Zeitschrift Crystal Growth & Design, online erschienen am 05.08.2025. Verfasst von Mei-Ling Ren und 10 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China, Natural Science Foundation of Jiangxi Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangxi Province
- Jiangxi Provincial Key Laboratory of Functional Crystalline Materials Chemistry
- Science and Technology Project of Jiangxi Provincial Department of Education
Zitieren
APA
Ren, M., Song, S., Xu, Z., Li, H., Qiu, Z., Shen, L., Zhang, X., Shi, C., Wang, N., Ye, H., & Miao, L. (2025). F-Substitution for Achieving Multiferroicity in In (III)-Based Two-Dimensional Organic–Inorganic Hybrid Halogen Double Perovskites. Crystal Growth & Design, 25(16), 6803-6809. https://doi.org/10.1021/acs.cgd.5c00747
Vancouver
Ren M, Song S, Xu Z, Li H, Qiu Z, Shen L, et al. F-Substitution for Achieving Multiferroicity in In (III)-Based Two-Dimensional Organic–Inorganic Hybrid Halogen Double Perovskites. Crystal Growth & Design. 2025;25(16):6803-6809. doi:10.1021/acs.cgd.5c00747
BibTeX
@article{Ren2025,
author = {Ren, Mei-Ling and Song, Shou-Feng and Xu, Ze-Jiang and Li, Hua-Kai and Qiu, Zi-Ao and Shen, Liang-Han and Zhang, Xiang and Shi, Chao and Wang, Na and Ye, Heng-Yun and Miao, Le-Ping},
title = {F-Substitution for Achieving Multiferroicity in In (III)-Based Two-Dimensional Organic–Inorganic Hybrid Halogen Double Perovskites},
journal = {Crystal Growth & Design},
year = {2025},
volume = {25},
number = {16},
pages = {6803--6809},
doi = {10.1021/acs.cgd.5c00747}
}
EUVIMED